Review



col3 ihc  (Huabio Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Huabio Inc col3 ihc
    Evaluation of the therapeutic efficacy after BPPNs treatment. ( A ) Effects of different preparations on SOD and MDA level on day 14. ( B ) Immunofluorescence staining of neovascularizationat the wound tissue with different treatments on day 14. α-SMA (green), CD31 (red), and DAPI (blue). Scale bar: 100 μm. ( C ) Quantitative analysis of the blood vessel density on day 14. ( D ) Corresponding immunohistochemistry staining of COX2, HO-1, Cyto C, VEGF and <t>COL3</t> on day 14. Scale bar: 200 μm. E - I . Immunohistochemical quantification of COX2, HO-1, HIF-1α, VEGF and COL3, respectively. n = 5, * P < 0.05, ** P < 0.01, *** P < 0.005
    Col3 Ihc, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/col3 ihc/product/Huabio Inc
    Average 90 stars, based on 1 article reviews
    col3 ihc - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "High-throughput screening-based design of multifunctional natural polyphenol nano-vesicles to accelerate diabetic wound healing"

    Article Title: High-throughput screening-based design of multifunctional natural polyphenol nano-vesicles to accelerate diabetic wound healing

    Journal: Journal of Nanobiotechnology

    doi: 10.1186/s12951-024-02950-2

    Evaluation of the therapeutic efficacy after BPPNs treatment. ( A ) Effects of different preparations on SOD and MDA level on day 14. ( B ) Immunofluorescence staining of neovascularizationat the wound tissue with different treatments on day 14. α-SMA (green), CD31 (red), and DAPI (blue). Scale bar: 100 μm. ( C ) Quantitative analysis of the blood vessel density on day 14. ( D ) Corresponding immunohistochemistry staining of COX2, HO-1, Cyto C, VEGF and COL3 on day 14. Scale bar: 200 μm. E - I . Immunohistochemical quantification of COX2, HO-1, HIF-1α, VEGF and COL3, respectively. n = 5, * P < 0.05, ** P < 0.01, *** P < 0.005
    Figure Legend Snippet: Evaluation of the therapeutic efficacy after BPPNs treatment. ( A ) Effects of different preparations on SOD and MDA level on day 14. ( B ) Immunofluorescence staining of neovascularizationat the wound tissue with different treatments on day 14. α-SMA (green), CD31 (red), and DAPI (blue). Scale bar: 100 μm. ( C ) Quantitative analysis of the blood vessel density on day 14. ( D ) Corresponding immunohistochemistry staining of COX2, HO-1, Cyto C, VEGF and COL3 on day 14. Scale bar: 200 μm. E - I . Immunohistochemical quantification of COX2, HO-1, HIF-1α, VEGF and COL3, respectively. n = 5, * P < 0.05, ** P < 0.01, *** P < 0.005

    Techniques Used: Drug discovery, Immunofluorescence, Staining, Immunohistochemistry, Immunohistochemical staining

    Primary antibodies were used in the study
    Figure Legend Snippet: Primary antibodies were used in the study

    Techniques Used:



    Similar Products

    col3 ihc  (Huabio Inc)
    90
    Huabio Inc col3 ihc
    Evaluation of the therapeutic efficacy after BPPNs treatment. ( A ) Effects of different preparations on SOD and MDA level on day 14. ( B ) Immunofluorescence staining of neovascularizationat the wound tissue with different treatments on day 14. α-SMA (green), CD31 (red), and DAPI (blue). Scale bar: 100 μm. ( C ) Quantitative analysis of the blood vessel density on day 14. ( D ) Corresponding immunohistochemistry staining of COX2, HO-1, Cyto C, VEGF and <t>COL3</t> on day 14. Scale bar: 200 μm. E - I . Immunohistochemical quantification of COX2, HO-1, HIF-1α, VEGF and COL3, respectively. n = 5, * P < 0.05, ** P < 0.01, *** P < 0.005
    Col3 Ihc, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/col3 ihc/product/Huabio Inc
    Average 90 stars, based on 1 article reviews
    col3 ihc - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    col3 ihc #er1906-50  (Huabio Inc)
    90
    Huabio Inc col3 ihc #er1906-50
    Evaluation of the therapeutic efficacy after BPPNs treatment. ( A ) Effects of different preparations on SOD and MDA level on day 14. ( B ) Immunofluorescence staining of neovascularizationat the wound tissue with different treatments on day 14. α-SMA (green), CD31 (red), and DAPI (blue). Scale bar: 100 μm. ( C ) Quantitative analysis of the blood vessel density on day 14. ( D ) Corresponding immunohistochemistry staining of COX2, HO-1, Cyto C, VEGF and <t>COL3</t> on day 14. Scale bar: 200 μm. E - I . Immunohistochemical quantification of COX2, HO-1, HIF-1α, VEGF and COL3, respectively. n = 5, * P < 0.05, ** P < 0.01, *** P < 0.005
    Col3 Ihc #Er1906 50, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/col3 ihc #er1906-50/product/Huabio Inc
    Average 90 stars, based on 1 article reviews
    col3 ihc #er1906-50 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Evaluation of the therapeutic efficacy after BPPNs treatment. ( A ) Effects of different preparations on SOD and MDA level on day 14. ( B ) Immunofluorescence staining of neovascularizationat the wound tissue with different treatments on day 14. α-SMA (green), CD31 (red), and DAPI (blue). Scale bar: 100 μm. ( C ) Quantitative analysis of the blood vessel density on day 14. ( D ) Corresponding immunohistochemistry staining of COX2, HO-1, Cyto C, VEGF and COL3 on day 14. Scale bar: 200 μm. E - I . Immunohistochemical quantification of COX2, HO-1, HIF-1α, VEGF and COL3, respectively. n = 5, * P < 0.05, ** P < 0.01, *** P < 0.005

    Journal: Journal of Nanobiotechnology

    Article Title: High-throughput screening-based design of multifunctional natural polyphenol nano-vesicles to accelerate diabetic wound healing

    doi: 10.1186/s12951-024-02950-2

    Figure Lengend Snippet: Evaluation of the therapeutic efficacy after BPPNs treatment. ( A ) Effects of different preparations on SOD and MDA level on day 14. ( B ) Immunofluorescence staining of neovascularizationat the wound tissue with different treatments on day 14. α-SMA (green), CD31 (red), and DAPI (blue). Scale bar: 100 μm. ( C ) Quantitative analysis of the blood vessel density on day 14. ( D ) Corresponding immunohistochemistry staining of COX2, HO-1, Cyto C, VEGF and COL3 on day 14. Scale bar: 200 μm. E - I . Immunohistochemical quantification of COX2, HO-1, HIF-1α, VEGF and COL3, respectively. n = 5, * P < 0.05, ** P < 0.01, *** P < 0.005

    Article Snippet: COL3 , IHC , #ER1906-50, Huabio, China.

    Techniques: Drug discovery, Immunofluorescence, Staining, Immunohistochemistry, Immunohistochemical staining

    Primary antibodies were used in the study

    Journal: Journal of Nanobiotechnology

    Article Title: High-throughput screening-based design of multifunctional natural polyphenol nano-vesicles to accelerate diabetic wound healing

    doi: 10.1186/s12951-024-02950-2

    Figure Lengend Snippet: Primary antibodies were used in the study

    Article Snippet: COL3 , IHC , #ER1906-50, Huabio, China.

    Techniques: